Molecular Features of Androgen-Receptor Low, Estrogen Receptor-Negative Breast Cancers in the Carolina Breast Cancer Study

Mostrar otras versiones (1)

PURPOSE: Androgen receptor (AR) expression is absent in 40–90% of estrogen receptor (ER)-negative breast cancers. The prognostic value of AR in ER-negative patients and therapeutic targets for patients absent in AR remains poorly explored. METHODS: We used an RNA-based multigene classifier to identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jinna, Nikita, Van Alsten, Sarah, Rida, Padmashree, Seewaldt, Victoria, Troester, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055609/
https://www.ncbi.nlm.nih.gov/pubmed/36993425
http://dx.doi.org/10.21203/rs.3.rs-2693555/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055609/
https://www.ncbi.nlm.nih.gov/pubmed/36993425
http://dx.doi.org/10.21203/rs.3.rs-2693555/v1

Ejemplares similares